US5352050A
(en)
*
|
1992-07-27 |
1994-10-04 |
Choate John I M |
Keyboard arrangement to maximize typing speed and ease of transition from a QWERTY keyboard
|
US5498088A
(en)
*
|
1992-07-27 |
1996-03-12 |
Choate; John I. M. |
Keyboard arrangement to maximize typing speed and ease of transition from a qwerty keyboard
|
US5836705A
(en)
*
|
1992-07-27 |
1998-11-17 |
Choate; John I. M. |
Keyboard arrangement to maximize typing speed and data entry and to ease transition from a qwerty keyboard
|
DK72793D0
(da)
*
|
1993-06-21 |
1993-06-21 |
Novo Nordisk As |
Nyt produkt
|
US5461031A
(en)
*
|
1994-06-16 |
1995-10-24 |
Eli Lilly And Company |
Monomeric insulin analog formulations
|
US5474978A
(en)
*
|
1994-06-16 |
1995-12-12 |
Eli Lilly And Company |
Insulin analog formulations
|
US5547929A
(en)
*
|
1994-09-12 |
1996-08-20 |
Eli Lilly And Company |
Insulin analog formulations
|
US5693609A
(en)
*
|
1994-11-17 |
1997-12-02 |
Eli Lilly And Company |
Acylated insulin analogs
|
AR002976A1
(es)
*
|
1995-03-31 |
1998-05-27 |
Lilly Co Eli |
Formulaciones farmaceuticas parenterales de efecto prolongado de insulina; cristales de dichos analogos aplicables en dichas formulaciones yprocedimiento de las formulaciones mencionadas
|
DE69630527T2
(de)
*
|
1995-06-30 |
2004-08-05 |
Novo Nordisk A/S |
Vorbeugung einer krankheit mit diabetes charakter
|
RU2182015C2
(ru)
*
|
1996-06-20 |
2002-05-10 |
Ново Нордиск А/С |
ПРЕПАРАТ ИНСУЛИНА, СОДЕРЖАЩИЙ NaCl, ПАРЕНТЕРАЛЬНАЯ ГОТОВАЯ ФОРМА, СПОСОБ ПОВЫШЕНИЯ ХИМИЧЕСКОЙ СТАБИЛЬНОСТИ ПРЕПАРАТА ИНСУЛИНА
|
AR012894A1
(es)
*
|
1997-06-13 |
2000-11-22 |
Lilly Co Eli |
Formulacion de insulina en solucion estable, su uso para preparar un medicamento y proceso para la preparacion de la misma.
|
IL134901A0
(en)
|
1997-10-24 |
2001-05-20 |
Lilly Co Eli |
Insoluble insulin compositions
|
US6531448B1
(en)
|
1997-12-23 |
2003-03-11 |
Eli Lilly And Company |
Insoluble compositions for controlling blood glucose
|
DE69924232D1
(de)
*
|
1998-01-09 |
2005-04-21 |
Novo Nordisk As |
Stabilisierte insulin-zubereitungen
|
KR20010080132A
(ko)
*
|
1998-10-16 |
2001-08-22 |
한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 |
멘톨을 포함하는 폐 송달을 위한 인슐린 조제물
|
US6211144B1
(en)
|
1998-10-16 |
2001-04-03 |
Novo Nordisk A/S |
Stable concentrated insulin preparations for pulmonary delivery
|
US6635617B1
(en)
|
1998-10-16 |
2003-10-21 |
Novo Nordisk A/S |
Insulin preparations for pulmonary delivery containing menthol
|
IL142011A0
(en)
*
|
1998-10-16 |
2002-03-10 |
Novo Nordisk As |
Stable concentrated insulin preparations for pulmonary delivery
|
ATE259653T1
(de)
*
|
1998-11-18 |
2004-03-15 |
Novo Nordisk As |
Stabile wässrige insulinzubereitungen ohne phenol und kresol
|
US6489292B1
(en)
|
1998-11-18 |
2002-12-03 |
Novo Nordisk A/S |
Stable aqueous insulin preparations without phenol and cresol
|
US20040214747A1
(en)
*
|
1999-01-06 |
2004-10-28 |
Dimarchi Richard Dennis |
Method for administering monomeric insulin
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
US6734162B2
(en)
|
2000-01-24 |
2004-05-11 |
Minimed Inc. |
Mixed buffer system for stabilizing polypeptide formulations
|
DK1383540T3
(da)
*
|
2000-07-31 |
2009-08-24 |
Univ Bar Ilan |
Fremgangsmdåer og farmaceutiske sammensætninger til sårheling
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
DE10114178A1
(de)
*
|
2001-03-23 |
2002-10-10 |
Aventis Pharma Gmbh |
Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
|
US6737401B2
(en)
*
|
2001-06-28 |
2004-05-18 |
Metronic Minimed, Inc. |
Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
|
EP1469827B1
(en)
|
2002-01-09 |
2017-12-27 |
Emisphere Technologies, Inc. |
Polymorphs of sodium 4- (4-chloro-2-hydroxybenzoyl)amino butanoate
|
US20030211976A1
(en)
*
|
2002-03-07 |
2003-11-13 |
Andreasen Kasper Huus |
Polyamino acid-based particle insulin formulation
|
US20040005999A1
(en)
*
|
2002-03-07 |
2004-01-08 |
Andreasen Kasper Huus |
Polyamino acid-based particle insulin preparation
|
DE10227232A1
(de)
*
|
2002-06-18 |
2004-01-15 |
Aventis Pharma Deutschland Gmbh |
Saure Insulinzubereitungen mit verbesserter Stabilität
|
US20060258561A1
(en)
*
|
2003-03-13 |
2006-11-16 |
Novo Nordisk A/S |
Novel NPH insulin preparations
|
US7547821B2
(en)
|
2003-06-17 |
2009-06-16 |
Sembiosys Genetics Inc. |
Methods for the production of insulin in plants
|
WO2005012346A1
(en)
*
|
2003-07-25 |
2005-02-10 |
Conjuchem, Inc. |
Long lasting insulin derivatives and methods thereof
|
CA2553392A1
(en)
*
|
2004-01-16 |
2005-08-11 |
Biodel Inc |
Sublingual drug delivery device
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
US20080096800A1
(en)
*
|
2004-03-12 |
2008-04-24 |
Biodel, Inc. |
Rapid mucosal gel or film insulin compositions
|
US20080085298A1
(en)
*
|
2004-03-12 |
2008-04-10 |
Biodel, Inc. |
Rapid Mucosal Gel or Film Insulin Compositions
|
CN102001963B
(zh)
|
2004-05-06 |
2014-04-16 |
爱密斯菲尔科技公司 |
N-[8-(2-羟基苯甲酰基)氨基]辛酸一钠的晶体的多晶
|
WO2005117854A2
(en)
*
|
2004-05-14 |
2005-12-15 |
Emisphere Technologies, Inc. |
Aryl ketone compounds and compositions for delivering active agents
|
EP1750674A4
(en)
*
|
2004-05-27 |
2012-05-23 |
Advanced Bionutrition Corp |
MICROPARTICLES FOR THE ORAL LEVY
|
US7872095B2
(en)
|
2004-07-19 |
2011-01-18 |
Biocon Limited |
Insulin-oligomer conjugates, formulations and uses thereof
|
US20100048454A1
(en)
*
|
2004-08-03 |
2010-02-25 |
Emisphere Technologies, Inc. |
Antidiabetic oral insulin-biguanide combination
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
JP2008509933A
(ja)
*
|
2004-08-13 |
2008-04-03 |
エミスフェアー・テクノロジーズ・インク |
送達剤のマイクロ粒子またはナノ粒子を含む医薬製剤
|
PT2918286T
(pt)
*
|
2004-10-05 |
2020-03-27 |
Novo Nordisk As |
Formulação farmacêutica
|
CN101060856B
(zh)
|
2004-11-22 |
2011-01-19 |
诺和诺德公司 |
可溶、稳定的含胰岛素制剂
|
US7833513B2
(en)
|
2004-12-03 |
2010-11-16 |
Rhode Island Hospital |
Treatment of Alzheimer's Disease
|
EP1862174A1
(en)
*
|
2005-03-02 |
2007-12-05 |
Ajinomoto Co., Inc. |
Inhibitor for insulin polymer formation
|
NZ566083A
(en)
|
2005-08-29 |
2012-11-30 |
Healor Ltd |
Methods and compositions for prevention and treatment of diabetic and aged skin
|
CN101627011A
(zh)
|
2005-09-19 |
2010-01-13 |
爱密斯菲尔科技公司 |
N-(5-氯水杨酰基)-8-氨基辛酸的二钠盐的晶形
|
US8084420B2
(en)
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US7713929B2
(en)
*
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
EP1991575A1
(en)
*
|
2006-02-21 |
2008-11-19 |
Novo Nordisk A/S |
Single-chain insulin analogues and pharmaceutical formulations thereof
|
US8927015B2
(en)
|
2006-04-12 |
2015-01-06 |
Emisphere Technologies, Inc. |
Formulations for delivering insulin
|
AU2007238114B2
(en)
|
2006-04-12 |
2010-10-14 |
Biodel, Inc. |
Rapid acting and long acting insulin combination formulations
|
WO2008043033A2
(en)
|
2006-10-04 |
2008-04-10 |
Case Western Reserve University |
Fibrillation-resistant insulin and insulin analogues
|
CA2681158C
(en)
|
2007-03-13 |
2018-09-18 |
Nutrition 21, Inc. |
Methods and compositions for the sustained release of chromium
|
US8466199B2
(en)
*
|
2007-03-21 |
2013-06-18 |
Emisphere Technologies, Inc. |
Allyloxy and alkyloxy benzoic acid delivery agents
|
EP2514412A1
(en)
*
|
2007-04-30 |
2012-10-24 |
Novo Nordisk A/S |
Highly Concentrated Insulin Solutions and Compositions
|
WO2009002867A2
(en)
|
2007-06-26 |
2008-12-31 |
Nutrition 21, Inc. |
Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
|
KR101234540B1
(ko)
|
2007-10-16 |
2013-02-19 |
바이오콘 리미티드 |
경구 투여가능한 고형 약제학적 조성물 및 그 제조방법
|
KR101344369B1
(ko)
|
2007-11-02 |
2013-12-24 |
에미스페어 테크놀로지스, 인코포레이티드 |
비타민 b12 결핍 치료방법
|
MY158627A
(en)
|
2008-07-31 |
2016-10-31 |
Univ Case Western Reserve |
Halogen-stabilized insulin
|
CN102209541B
(zh)
|
2008-09-08 |
2016-05-18 |
小利兰·斯坦福大学托管委员会 |
醛脱氢酶活性调节剂和其使用方法
|
PT3228320T
(pt)
|
2008-10-17 |
2020-03-26 |
Sanofi Aventis Deutschland |
Combinação de uma insulina e de um agonista do glp-1
|
KR20110082180A
(ko)
|
2008-10-28 |
2011-07-18 |
더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 |
알데히드 탈수소효소의 조절자 및 그것의 사용방법
|
CA2750252A1
(en)
|
2009-01-28 |
2010-08-05 |
Smartcells, Inc. |
Synthetic conjugates and uses thereof
|
SG2014006597A
(en)
|
2009-01-28 |
2014-04-28 |
Smartcells Inc |
Conjugate based systems for controlled drug delivery
|
CN102316892B
(zh)
|
2009-02-12 |
2014-06-04 |
西马生物医学计划公司 |
心肌营养素-1用于治疗代谢病的用途
|
US9060927B2
(en)
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
JP2012520879A
(ja)
|
2009-03-20 |
2012-09-10 |
スマートセルズ・インコーポレイテツド |
末端官能基化コンジュゲートおよびその用途
|
US10029011B2
(en)
|
2009-11-13 |
2018-07-24 |
Sanofi-Aventis Deutschland Gmbh |
Pharmaceutical composition comprising a GLP-1 agonist, an insulin and methionine
|
PT2498801T
(pt)
|
2009-11-13 |
2018-05-02 |
Sanofi Aventis Deutschland |
Composição farmacêutica compreendendo despro36exendin-4(1-39)-lys6-nh2 e metionina
|
EP2536421A4
(en)
|
2010-01-11 |
2013-10-09 |
Healor Ltd |
METHOD FOR THE TREATMENT OF DANDRUFFS
|
AR080292A1
(es)
*
|
2010-02-24 |
2012-03-28 |
Emisphere Tech Inc |
Metodo para normalizar en forma rapida los niveles de vitamina b12 en un paciente que tiene deficiencia de vitamina b12 y un nivel promedio de vitamina b12 por debajo de 350 pg/ml
|
SG187904A1
(en)
|
2010-08-30 |
2013-04-30 |
Sanofi Aventis Deutschland |
Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
|
CN107759771A
(zh)
|
2010-09-30 |
2018-03-06 |
索尔维公司 |
天然来源的环氧氯丙烷的衍生物
|
WO2012115641A1
(en)
|
2011-02-23 |
2012-08-30 |
Elona Biotechnologies |
Lis-pro proinsulin compositions and methods of producing lis-pro insulin analogs therefrom
|
CA2828572C
(en)
|
2011-03-01 |
2021-02-23 |
Jds Therapeutics, Llc |
Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders
|
US10457659B2
(en)
|
2011-04-29 |
2019-10-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for increasing proliferation of adult salivary stem cells
|
US9821032B2
(en)
|
2011-05-13 |
2017-11-21 |
Sanofi-Aventis Deutschland Gmbh |
Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
|
KR101983982B1
(ko)
|
2011-08-29 |
2019-05-30 |
사노피-아벤티스 도이칠란트 게엠베하 |
2형 당뇨병 환자의 혈당 조절에 사용하기 위한 약제학적 병용물
|
AR087744A1
(es)
|
2011-09-01 |
2014-04-16 |
Sanofi Aventis Deutschland |
Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
|
SG11201401835VA
(en)
|
2011-10-27 |
2014-09-26 |
Univ Case Western Reserve |
Ultra-concentrated rapid-acting insulin analogue formulations
|
WO2014004278A1
(en)
*
|
2012-06-26 |
2014-01-03 |
The Curators Of The University Of Missouri |
Photocleavable drug conjugates
|
DK2877200T3
(da)
|
2012-07-17 |
2019-08-12 |
Univ Case Western Reserve |
O-bundne carbonhydratmodificerede insulinanaloger
|
EA034393B1
(ru)
|
2012-11-13 |
2020-02-03 |
Адосиа |
Состав инсулина быстрого действия, содержащий замещенное анионное соединение
|
JP6735561B2
(ja)
|
2012-12-03 |
2020-08-05 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
O−グリコシル化カルボキシ末端部分(ctp)ペプチド系のインスリンおよびインスリン類似体
|
BR112015011179A8
(pt)
|
2012-12-19 |
2019-10-01 |
Wockhardt Ltd |
composições farmacêuticas aquosas estáveis compreendendo insulina humana ou um análogo ou derivado das mesmas, seu uso e processos para sua preparação
|
WO2014102623A1
(en)
|
2012-12-26 |
2014-07-03 |
Wockhardt Limited |
Pharmaceutical composition
|
CN105358531B
(zh)
|
2013-03-14 |
2017-11-14 |
利兰-斯坦福大学初级学院的董事会 |
线粒体醛脱氢酶‑2调节剂和其使用方法
|
TW201605489A
(zh)
|
2013-10-25 |
2016-02-16 |
賽諾菲公司 |
賴谷胰島素(insulin glulisine)的穩定調配物
|
WO2016032869A1
(en)
|
2014-08-26 |
2016-03-03 |
Merck Sharp & Dohme Corp. |
Method for preparing crystalline insulin or insulin analog compositions
|
NZ733670A
(en)
|
2014-12-12 |
2021-12-24 |
Sanofi Aventis Deutschland |
Insulin glargine/lixisenatide fixed ratio formulation
|
AR102869A1
(es)
|
2014-12-16 |
2017-03-29 |
Lilly Co Eli |
Composiciones de insulina de rápida acción
|
TWI748945B
(zh)
|
2015-03-13 |
2021-12-11 |
德商賽諾菲阿凡提斯德意志有限公司 |
第2型糖尿病病患治療
|
TW201705975A
(zh)
|
2015-03-18 |
2017-02-16 |
賽諾菲阿凡提斯德意志有限公司 |
第2型糖尿病病患之治療
|
JO3749B1
(ar)
|
2015-08-27 |
2021-01-31 |
Lilly Co Eli |
تركيبات إنسولين سريعة المفعول
|
US11865121B2
(en)
|
2016-02-11 |
2024-01-09 |
Nutrition21, LLC |
Chromium containing compositions for improving health and fitness
|
EA201992351A1
(ru)
|
2017-06-01 |
2020-03-26 |
Эли Лилли Энд Компани |
Быстродействующие композиции инсулина
|
WO2019125878A1
(en)
|
2017-12-18 |
2019-06-27 |
Merck Sharp & Dohme Corp. |
Conjugate based systems for controlled insulin delivery
|
WO2019125879A2
(en)
|
2017-12-18 |
2019-06-27 |
Merck Sharp & Dohme Corp. |
Conjugate based systems for controlled insulin delivery
|
US11951186B2
(en)
|
2019-10-25 |
2024-04-09 |
Willow Laboratories, Inc. |
Indicator compounds, devices comprising indicator compounds, and methods of making and using the same
|
AU2021247169A1
(en)
|
2020-03-31 |
2022-10-20 |
Protomer Technologies Inc. |
Conjugates for selective responsiveness to vicinal diols
|
AU2021382599A1
(en)
|
2020-11-19 |
2023-06-22 |
Protomer Technologies Inc. |
Aromatic boron-containing compounds and insulin analogs
|
WO2023225534A1
(en)
|
2022-05-18 |
2023-11-23 |
Protomer Technologies Inc. |
Aromatic boron-containing compounds and related insulin analogs
|